Dong-A St (KO:170900) — Market Cap & Net Worth
Market Cap & Net Worth: Dong-A St (170900)
Dong-A St (KO:170900) has a market capitalization of $275.09 Million (₩405.93 Billion) as of May 2, 2026. Listed on the KO stock exchange, this Korea-based company holds position #15331 globally and #573 in its home market, demonstrating a -0.34% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Dong-A St's stock price ₩44300.00 by its total outstanding shares 9163209 (9.16 Million). Analyse how efficiently does Dong-A St generate cash to see how efficiently the company converts income to cash.
Dong-A St Market Cap History: 2015 to 2026
Dong-A St's market capitalization history from 2015 to 2026. Data shows change from $813.18 Million to $275.09 Million (-7.96% CAGR).
Dong-A St Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Dong-A St's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Dong-A St's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $813.18 Million | $567.94 Billion | $48.56 Billion | 0.00x | 0.02x |
| 2016 | $586.83 Million | $560.54 Billion | $10.63 Billion | 0.00x | 0.06x |
| 2017 | $556.84 Million | $555.03 Billion | -$5.40 Billion | 0.00x | N/A |
| 2018 | $589.75 Million | $567.43 Billion | $8.01 Billion | 0.00x | 0.07x |
| 2019 | $677.37 Million | $612.31 Billion | $70.91 Billion | 0.00x | 0.01x |
| 2020 | $510.27 Million | $586.73 Billion | $27.10 Billion | 0.00x | 0.02x |
| 2021 | $418.13 Million | $593.23 Billion | $12.82 Billion | 0.00x | 0.03x |
| 2022 | $366.29 Million | $635.39 Billion | $13.55 Billion | 0.00x | 0.03x |
| 2023 | $429.10 Million | $663.98 Billion | $11.12 Billion | 0.00x | 0.04x |
| 2024 | $365.13 Million | $697.87 Billion | -$1.22 Billion | 0.00x | N/A |
Competitor Companies of 170900 by Market Capitalization
Companies near Dong-A St in the global market cap rankings as of May 2, 2026.
Key companies related to Dong-A St by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.09 |
Dong-A St Historical Marketcap From 2015 to 2026
Between 2015 and today, Dong-A St's market cap moved from $813.18 Million to $ 275.09 Million, with a yearly change of -7.96%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩275.09 Million | -15.62% |
| 2025 | ₩326.01 Million | -10.71% |
| 2024 | ₩365.13 Million | -14.91% |
| 2023 | ₩429.10 Million | +17.15% |
| 2022 | ₩366.29 Million | -12.40% |
| 2021 | ₩418.13 Million | -18.06% |
| 2020 | ₩510.27 Million | -24.67% |
| 2019 | ₩677.37 Million | +14.86% |
| 2018 | ₩589.75 Million | +5.91% |
| 2017 | ₩556.84 Million | -5.11% |
| 2016 | ₩586.83 Million | -27.84% |
| 2015 | ₩813.18 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Dong-A St was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $275.09 Million USD |
| MoneyControl | $275.09 Million USD |
| MarketWatch | $275.09 Million USD |
| marketcap.company | $275.09 Million USD |
| Reuters | $275.09 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Dong-A St
Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products in South Korea and internationally. It offers various ethical drugs, including Clofazimine cap. For lepromatous leprosy; Closerin Cap for active pulmonary and extra-pulmonary tuberculosis; Eporon inj./PFS for anemia associated with chronic renal failure; Gemcit inj. to treat non-small cell lung, pancreatic, breast, bl… Read more